Is it okay to take lamivudine dolutegravir tablets (Dovito) blocker after high-risk sexual intercourse?

Lamivudine dolutegravir (Dovito) is not generally used as a HIV post-exposure prophylaxis (Post-Exposure Prophylaxis, PEP) medication. PEPis a strategy used to prevent HIV infection, usually after high-risk sexual behavior, such as unprotected sex or sexual contact with a person known to be HIV infected. The goal of PEP is to stop the spread of HIV infection as early as possible, but lamivudine dolutegravir is not usually the drug of choice.

PEP typically involves the use of three different classes of anti-HIV drugs, typically a combination of nucleoside reverse transcriptase inhibitors (NRTI) and integrase inhibitors (INSTI), to ensure optimal antiviral coverage.

If you think you have engaged in high-risk sexual behavior and are concerned you may have been exposed to HIV, talk to a medical professional or go to a hospital emergency room immediately. A medical professional will assess your risk and decide whether to give PEP treatment based on your situation. PEPTreatment usually needs to start as soon as possible after exposure, so it is important to seek early medical advice.

Remember, prevention is the best way. Avoiding high-risk sexual behaviors, using condoms, and getting regularHIVtests are effective measures to reduce the risk of HIV transmission. If you are concerned aboutHIV infection or have other related questions, please speak to a medical professional for the most appropriate advice and support.

Lamivudine dolutegravir tablets have been launched in China and have been included in medical insurance. Patients can buy them in domestic hospital pharmacies at a price of about more than 1,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement information. The cheaper ones abroad are mainly Indian generic drugs, which cost more than 200 yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.